Nightingale Health

Disease prediction from blood

Helsinki, Finland

Nightingale Health leverages Nuclear Magnetic Resonance (NMR) spectroscopy to analyze approximately 250 biomarkers from blood samples. Their technology is used to identify early risk signs for common diseases like heart failure, dementia, and diabetes, offering chronic disease risk detection capabilities. The company focuses on B2B and B2G markets, with strategic partnerships for global scaling of its digital health solutions.

Shareable draft

Check out Nightingale Health on @MedStartr Today Nightingale Health leverages Nuclear Magnetic Resonance (NMR) spectroscopy to analyze approximately 250 biomarkers from blood samples. Their technology is used to identify early risk signs for common diseases like heart failure, dementia, and diabetes, offering chronic disease risk detection capabilities. The company focuses on B2B and B2G markets, with strategic partnerships for global scaling of its digital health solutions. #AcuteDecompensatedHeartFailure #MentalBehavioralHealth #AlzheimerSDiseaseDementia #HeartFailure #Diabetes #ChronicDiseases #PrecisionMedicineDiagnostics #MedMo #MedStartrVentures

https://www.medstartr.ai/s/BPGjxAqQ01I

Get Involved in Nightingale Health

How We Help

Core Technology

Nuclear Magnetic Resonance (NMR) spectroscopy to measure approximately 250 active biomarkers from a single blood sample

Clinical Focus

chronic disease risk detection

Company Info

Business Model: Licensing
Founded: 2013
Total Funding: Only accessible to MedStartr community members. Join now
Only accessible to MedStartr community members.
Join now

Disease Areas

Acute Decompensated Heart Failure Mental Health Alzheimer's & Dementia Heart Failure Diabetes Chronic Diseases

Technologies

NMR SpectroscopyBiomarkers

Clinical & IP

🔬

Clinical Validation

Nature Communications 2024: Metabolomic scores predict disease onset better than polygenic scores in 700,217 participants. Landmark study shows 44% improvement in cardiovascular event prevention. 39 CE-marked biomarkers. Validated in UK Biobank (118,461 participants) and international cohorts.

MedStartr Engagement Score

The MedStartr Index is a reflection of how the crowds that come to MedStartr everyday to find healthcare innovations reacted. Calculated by our AI agent Fyggy based on algorithms we have been building since 2012 and over 100 different factors, the math is proprietary and complex. Suffice to say, it has been found to be highly correlative with early stage company growth. What you see here is the public version. To learn more or to get deeper access to our predictive data on startup success for your fund or company, click here.

Comments

Comments from new members are shown once the company's team has approved them. Please follow the community rules.

Be the first to comment.

What do you think of Nightingale Health?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Clinical Benefit Potential

The potential for a project to have a large and significant impact on medical care, treatment, or prevention.

Feasibility

The likelihood that this will provide benefit for patients / care givers and that the founders can execute on their vision and plan.

Innovativeness

The distinguishing features, concept, or technology that differentiates the entry compared to others that already exist and are in widespread use.

Fundability

The reviewers' beliefs that the idea is fundable or can make it to sustainability without outside investment.

Scalability

Some great ideas are destined to failure because they are too complex or too expensive. The reviewer should consider the likelihood that a project as explained, or perhaps with some tweaks, could possibly become a worldwide solution within a reasonable time frame.

Presentation Quality

How well the team presented the idea.

Submit anonymously — my name won't be shown to the team or on this profile

Your scores and comments are shown with your review on this company's profile.